Latest / Wellness, Actually with Emily Oster & Perry Wilson, MD / What's the deal with testosterone?
Transcript
- 0:01Speaker 1: Emily, I'm very excited for this episode about testosterone, as
- 0:06Speaker 1: you know, we you know, we just did the Hormone
- 0:08Speaker 1: replacement Therapy SOR for women episode last week, and honestly,
- 0:12Speaker 1: there is a vast deference between estrogen and testosterone, and
- 0:18Speaker 1: I'm excited to explore that. I think this is going
- 0:20Speaker 1: to be a seminal episode.
- 0:24Speaker 2: I can't even react to you, but I will say
- 0:27Speaker 2: that last week you gave a whole long open about
- 0:31Speaker 2: how you weren't going to talk about mint.
- 0:32Speaker 3: You weren't going a man's plain. You're working a blah
- 0:34Speaker 3: blah blah. I'm not giving that.
- 0:36Speaker 1: I am going a woman's plain all over.
- 0:38Speaker 3: I am a woman's plain. I'm not sorry.
- 0:40Speaker 2: I'm going to say all kinds of feelings I have
- 0:42Speaker 2: about testosterone and science, and even though I only have
- 0:47Speaker 2: a little bit of it, I assume.
- 0:50Speaker 1: I mean, Emily, I'm glad that you have the balls
- 0:53Speaker 1: to uh to really address this. Okay, I think I
- 0:56Speaker 1: have about eight more.
- 0:57Speaker 2: Yeah, you know what, I think that was three was
- 0:59Speaker 2: really good through vast Deeferens was.
- 1:01Speaker 3: Definitely the best.
- 1:02Speaker 2: The balls kind of is low, and so that's where
- 1:04Speaker 2: I think we should just move forward.
- 1:06Speaker 1: Okay, all right, Testosterone in a nutshell After the break.
- 1:13Speaker 2: I'm Emily Astro, I'm an economist and a data expert.
- 1:16Speaker 1: And I'm Perry Wilson, I'm a medical doctor.
- 1:19Speaker 2: It's Thursday, April thirtieth, twenty twenty six.
- 1:22Speaker 3: And this is wellness.
- 1:23Speaker 1: Actually, because you're getting a staggering amount of health and
- 1:27Speaker 1: wellness information nowadays from every source imaginable, and some of
- 1:31Speaker 1: it is awesome and some.
- 1:33Speaker 3: Of it is well actually both.
- 1:37Speaker 2: Fortunately, we're both people who know how to read studies,
- 1:40Speaker 2: how to parse the data, and can tell you what's
- 1:42Speaker 2: worth thinking about and what you can safely ignore.
- 1:45Speaker 1: But before we dig in, a note that this podcast
- 1:48Speaker 1: is for educational purposes and should not be construed as
- 1:50Speaker 1: medical advice. We don't know your unique situation, so talk
- 1:54Speaker 1: to your doctor for personal health decisions.
- 1:57Speaker 2: This week we're asking what's the deal with testosterone.
- 2:01Speaker 3: It's part two of our hormone two parter.
- 2:04Speaker 2: Perry and I will give the official smash or pass,
- 2:06Speaker 2: and then we'll get to your question of the week.
- 2:08Speaker 2: But first let's do the health news roundup after the break,
- 2:24Speaker 2: and now for the health news of the week, Perry,
- 2:27Speaker 2: no more flu vaccine mandates for military troops. The Department
- 2:32Speaker 2: of Defense Pete Hegseth has said we will not be
- 2:36Speaker 2: having required flu vaccines for the military.
- 2:40Speaker 1: Your thoughts, Yeah, this is weird when it comes to
- 2:46Speaker 1: combat readiness. You know, the military has long and in
- 2:50Speaker 1: multiple domains, had less freedoms than the public sector or
- 2:57Speaker 1: than the rest of us. Right, you know, think about
- 2:59Speaker 1: like free speech, even there are limitations on that in
- 3:01Speaker 1: the military because it is a job that has obviously
- 3:06Speaker 1: very specific risks and is so vital to national security,
- 3:11Speaker 1: and combat readiness is in part determined by the health
- 3:16Speaker 1: of the troops in terms of infectious diseases. I mean,
- 3:18Speaker 1: if you look at like the history of warfare, you
- 3:21Speaker 1: would find that infection has killed vastly more soldiers than
- 3:28Speaker 1: combat is often responsible for losing the war. I mean,
- 3:33Speaker 1: one of the reasons the Americans were able to hold
- 3:36Speaker 1: out during the Revolutionary War was because Washington made the
- 3:40Speaker 1: rather bold and somewhat risky decision to force smallpox vaccination
- 3:45Speaker 1: or inoculation really on all the Revolutionary War troops. It's
- 3:50Speaker 1: hard not even speaking of just about influenza's kind of random. Obviously,
- 3:54Speaker 1: there's a bunch of vaccines that the troops, get me
- 3:58Speaker 1: ninjaccle disease, have a hepatitis B, pertussis, diphtheria, so many
- 4:04Speaker 1: So I don't know why we're isolating influenza. And like,
- 4:07Speaker 1: let's not forget that the worst influenza pandemic in history occurred.
- 4:13Speaker 1: This is the Spanish flu so called Spanish flu influenza
- 4:16Speaker 1: pandemic occurred after World War One because a bunch of
- 4:19Speaker 1: infected troops brought brought the virus home. So a weird decision.
- 4:24Speaker 1: It feels completely like brazenly sort of political to me,
- 4:29Speaker 1: I see no justification for this in a rational society.
- 4:32Speaker 2: Yeah, I mean, I will say I think this feels
- 4:34Speaker 2: like just a complete political move to me, in the
- 4:37Speaker 2: sense that it's, you know, relative to other vaccines they
- 4:41Speaker 2: could have turned against. I don't know why it's they
- 4:45Speaker 2: chose this one, but it's one that you know, people
- 4:47Speaker 2: are having every year, and there's a lot of political
- 4:50Speaker 2: resistance too, and so it feels like it's this or
- 4:54Speaker 2: the COVID vaccine. I think they already don't require the
- 4:56Speaker 2: covid vaccine, so that's I.
- 4:58Speaker 1: Think that's that's correct. Two viruses, by the way, that
- 5:02Speaker 1: just really enjoys spreading in close quarter conditions. It's pretty random. Okay,
- 5:12Speaker 1: let's move on. We have some fish oil news today,
- 5:16Speaker 1: but actually some bad fish oil news. So fish oil
- 5:19Speaker 1: supplementation pops up every once in a while. It's a
- 5:22Speaker 1: wellness trend. Like many supplement trends. The data has been
- 5:29Speaker 1: rather mixed. But we've got some new headlines coming out
- 5:31Speaker 1: this week that actually suggests that fish oil might hurt
- 5:35Speaker 1: your brain. This is kind of the opposite of what
- 5:38Speaker 1: a lot of people think about fish oil, like it's
- 5:40Speaker 1: going to keep me smarter, right, probably because it has
- 5:43Speaker 1: so much dolphin in it, and you know how smart
- 5:45Speaker 1: they are. That's a joy. That's a Simpsons reference for
- 5:49Speaker 1: the very old people. And Emily, what's going on is
- 5:52Speaker 1: fish oil going to hurt my brain?
- 5:54Speaker 2: Fish oil is not going to hurt your brain, or
- 5:57Speaker 2: at least not. There is no strong evidence for based
- 6:00Speaker 2: on this new research. And this is an example where
- 6:04Speaker 2: the distinction between what the headline said, which was literally
- 6:08Speaker 2: fish oil might hurt your brain, and what the actual
- 6:10Speaker 2: paper said was really vast. So there is a piece
- 6:14Speaker 2: of new research in which researchers took mice with traumatic
- 6:18Speaker 2: brain injury, so they actually took some mice, they gave
- 6:21Speaker 2: them a traumatic brain injury and then they treated them
- 6:24Speaker 2: with fish oil, and they found that the treatment with
- 6:28Speaker 2: fish oil did not improve the traumatic brain injury in
- 6:31Speaker 2: the mice, which they had thought that it might. And
- 6:34Speaker 2: so that is interesting, I guess, from the standpoint of
- 6:38Speaker 2: thinking about how we treat traumatic brain injury, which is
- 6:40Speaker 2: an important question, and certainly, you know, early stage mouse
- 6:43Speaker 2: research might be helpful for that. To go from treating
- 6:47Speaker 2: mice with traumatic brain injury with fish oil does not
- 6:49Speaker 2: improve them to fish oil might hurt your brain. Feels
- 6:52Speaker 2: like we took not just one, but like several very
- 6:56Speaker 2: large leaps.
- 6:59Speaker 1: Yeah. Yeah, well, well, obviously the mouse traumatic brain injury
- 7:04Speaker 1: readership is not as large as the humans worried about
- 7:07Speaker 1: their brain readership.
- 7:08Speaker 3: No they're not, No, they're not.
- 7:10Speaker 2: But it's I mean, it's such a strong example here
- 7:12Speaker 2: of where there is a piece of evidence in data
- 7:16Speaker 2: that actually is kind of interesting and I think should
- 7:19Speaker 2: be something we should pursue and learn more about. And
- 7:22Speaker 2: then it gets turned into some clickbait headline, because of
- 7:24Speaker 2: course the headline you know, mice with traumatic brain injury
- 7:27Speaker 2: don't necessarily improve with fish oil is not click is
- 7:31Speaker 2: not clique, it's not okay, let's do some some good news,
- 7:36Speaker 2: at least what looks to me to be good news.
- 7:39Speaker 2: It seems like we have started to make a little
- 7:42Speaker 2: bit of progress on pancreatic cancer, a couple of new
- 7:47Speaker 2: treatments that maybe are working.
- 7:51Speaker 3: Did you see this and what'd you think?
- 7:53Speaker 1: So exciting? So preliminary data presented at a cancer conference
- 7:57Speaker 1: out in California, so not pure reviewed yet, but still
- 8:02Speaker 1: super exciting. Two new and completely different approaches for pancreatic cancer.
- 8:08Speaker 1: The larger trial that was presented was of a drug
- 8:12Speaker 1: that I have some difficulty pronouncing, but I'm going to
- 8:16Speaker 1: go for it. It is called deraxnracib dere sonracib. This
- 8:23Speaker 1: is This is a novel RAS inhibitor. It was trialed
- 8:28Speaker 1: in five hundred and one patients with fairly advanced late
- 8:32Speaker 1: stage pancreatic cancer. Many people know that pancreatic cancer, particularly
- 8:37Speaker 1: late stage pancreatic cancer, has a very poor prognosis, with
- 8:42Speaker 1: an expected life expectancy generally less than a year after diagnosis.
- 8:47Speaker 1: That mortality rate at the time that they cut this
- 8:50Speaker 1: data and presented it was twice as long in the
- 8:53Speaker 1: patients that were randomized to receive this new therapy compared
- 8:55Speaker 1: to those randomized to receive placebo, about an extra six months.
- 9:00Speaker 1: This difference in life expectancy, which is very significant in
- 9:03Speaker 1: a pancreatic cancer trial, and obviously that's an average, and
- 9:06Speaker 1: some people are living substantially longer. So super exciting that
- 9:10Speaker 1: there's that new drug. Potentially, you know, a much smaller study,
- 9:15Speaker 1: but potentially even more exciting insofar as it is a
- 9:19Speaker 1: totally new avenue for cancer treatment. Researchers reported on patients
- 9:24Speaker 1: receiving a customized mr ANDA pancreatic cancer vaccine. So this
- 9:30Speaker 1: is where you take out a piece of the actual
- 9:34Speaker 1: patients pancreatic cancer, you do some genetic sequencing on it
- 9:38Speaker 1: to figure out where the mutations are. You create an
- 9:41Speaker 1: mRNA vaccine much like the COVID vaccine that's directed against
- 9:44Speaker 1: those very specific mutations, and you give that back to
- 9:48Speaker 1: the patient. This was not a randomized trial. This is
- 9:51Speaker 1: phase one therapy really just testing safety. But what the
- 9:54Speaker 1: researchers reported that of eight patients whose immune systems responded
- 10:01Speaker 1: to the mRNA so they have signals that their like
- 10:03Speaker 1: immune system got revved up to the vaccine, seven were alive.
- 10:08Speaker 1: Six years or more after receiving the last treatment. So
- 10:13Speaker 1: this is not necessarily a miracle. You have to respond
- 10:16Speaker 1: to the therapy. There's no placebo control here, which we
- 10:19Speaker 1: always talk about, but in a situation like pancreatic cancer,
- 10:23Speaker 1: you know, these advances can be super promising. So phase
- 10:26Speaker 1: one study Phase two will get started and give us
- 10:30Speaker 1: some better efficacy data, likely with a placebo control. Yeah.
- 10:33Speaker 2: I mean, this last one was really very exciting, given
- 10:36Speaker 2: that six years in pancreatic cancer is really out huture
- 10:40Speaker 2: on the tail and the idea that it's a sort
- 10:44Speaker 2: of new approach to this. It's very cool. Hopefully hopefully
- 10:49Speaker 2: more science as we go.
- 10:51Speaker 1: Yeah, and just another place where mRNA technology is making
- 10:57Speaker 1: an impact, and we're going to talk about this in
- 10:59Speaker 1: a future episode. People know about mRNA technology because of
- 11:03Speaker 1: the COVID vaccine, but what makes it so flexible is
- 11:06Speaker 1: that it can essentially be programmed to do what you
- 11:10Speaker 1: want it to do and to attack the specific thing
- 11:14Speaker 1: you wanted to attack, whether that's a COVID spike protein
- 11:17Speaker 1: or a protein on the surface of pancreatic cancer. Very cool.
- 11:20Speaker 3: All right, that's it for the health news of the week.
- 11:22Speaker 2: After the break what's the deal with testosterone? All right, Perry,
- 11:32Speaker 2: So let's talk about testosterone. Although I said, I'm not
- 11:37Speaker 2: going to be careful if I do get really out
- 11:39Speaker 2: on the tail of woman's plaining, joxtrap is your safe word.
- 11:44Speaker 3: Just say it and I will dial it right back in.
- 11:47Speaker 1: You got it. I appreciate it, thank you.
- 11:49Speaker 2: All right, So let's start with the big picture. What
- 11:51Speaker 2: is testosterone and what does it do for someone who
- 11:56Speaker 2: is totally unfamiliar.
- 11:58Speaker 1: So, testosterone is a steroid hormone. We talked about these
- 12:02Speaker 1: special types of molecules last week with the hormone replacement
- 12:05Speaker 1: therapy episode. But steroid hormones are unique in that they
- 12:10Speaker 1: act within the nucleus of the cell to change how
- 12:14Speaker 1: DNA is transcribed. So testosterone, estrogen, progesterone, some others all
- 12:20Speaker 1: work this way, and that's a function that really lets
- 12:23Speaker 1: them change how cells work. It can take a cell
- 12:26Speaker 1: that doesn't grow hair and change it into a cell
- 12:28Speaker 1: that does grow hair. Obviously, testosterone is the hormone that
- 12:33Speaker 1: makes men look like men. This is responsible for the
- 12:38Speaker 1: primary and secondary sexual characteristics of men. It certainly has
- 12:43Speaker 1: important roles in muscle growth. We'll get to that it's
- 12:46Speaker 1: necessary for sperm to be created. It has pretty significant
- 12:51Speaker 1: effects on erythropoesis or the generation of red blood cells,
- 12:56Speaker 1: and this is going to come up time and time again.
- 12:59Speaker 1: I don't know if we need an explicit warning on
- 13:01Speaker 1: this episode or not, but libido and sexual function is
- 13:06Speaker 1: clearly firmly within the testosterone wheelhouse.
- 13:10Speaker 2: Right, So if you're listening with your children, this episode
- 13:13Speaker 2: will discuss penises and sex, so.
- 13:16Speaker 3: Just be be aware, all right.
- 13:18Speaker 2: So when we start from the biggest picture here, there
- 13:21Speaker 2: are things which are definitely true, which is when boys
- 13:25Speaker 2: go through puberty, their.
- 13:27Speaker 3: Testosterone goes up.
- 13:29Speaker 2: And if that doesn't happen, if you have a medical
- 13:31Speaker 2: condition in which testosterone is lacking or is very low
- 13:36Speaker 2: for some reason, then you will need supplementation and that
- 13:41Speaker 2: that will affect the development of secondary sex characteristics. So
- 13:44Speaker 2: it's very clear that testosterone is important. Yeah, if we're
- 13:47Speaker 2: going to say, you know, smash or pass, like, do
- 13:50Speaker 2: we need testosterone as a species, like yes, yes, right,
- 13:54Speaker 2: It's not a useless peptide. It's an actual, important or important. Also,
- 14:00Speaker 2: some things that for sure are true, like if you
- 14:03Speaker 2: are a person doing sports and you give yourself a
- 14:06Speaker 2: bunch of extra testosterone. It will probably improve your sports performance,
- 14:10Speaker 2: but also.
- 14:11Speaker 3: That's cheating, so don't do that.
- 14:15Speaker 2: But I think there are a bunch of open, much
- 14:16Speaker 2: more interesting questions that relate to some of the wellness stuff,
- 14:19Speaker 2: which is, you know, how.
- 14:21Speaker 3: Much variation is there?
- 14:22Speaker 2: Does that variation actually matter, like within the normal range?
- 14:25Speaker 2: And if we supplement outside of a sports context, is
- 14:30Speaker 2: that going to improve our various sex activities and other stuff?
- 14:36Speaker 3: Are those for you the interesting sets of issues?
- 14:39Speaker 1: Yeah? Absolutely. I mean when people are asking me about
- 14:42Speaker 1: testosterone supplementation, they're not saying like I have a genetic
- 14:45Speaker 1: condition that prevents me from synthesizing testosterone, which will be
- 14:48Speaker 1: like one of the FDA indications for testosterone replacement. People
- 14:52Speaker 1: are asking, you know, these two things happen in parallel.
- 14:56Speaker 1: One men get older and two men's test osterone level
- 15:00Speaker 1: goes down a bit. And there's a natural question to say, like, well,
- 15:04Speaker 1: all these other things that happen when I get older,
- 15:07Speaker 1: like decreased energy, decrease libido. Maybe I feel like I'm
- 15:11Speaker 1: not quite as a top, quite as cognitively sharp as
- 15:14Speaker 1: I used to be, Like is that because of testosterone
- 15:18Speaker 1: or is it not? And if you go online you
- 15:21Speaker 1: will get plenty of people telling you absolutely it is
- 15:25Speaker 1: and please, you know, call this number to get testosterone
- 15:29Speaker 1: replacement therapy. But hopefully, if you're listening to the podcast,
- 15:32Speaker 1: that is not enough evidence for you. So I think
- 15:35Speaker 1: it's worth noting that the FDA indications for testostereplacement therapy
- 15:40Speaker 1: are quite limited. It is primary hypergonadism, which is like,
- 15:45Speaker 1: as you alluded to, like very rare genetic conditions that
- 15:48Speaker 1: prevent the production of testosterone in boys, you know, and
- 15:51Speaker 1: you need testosterone to grow into a man. The second
- 15:56Speaker 1: is pituitary hypogonadism, so your petuitary glands to creates a
- 16:00Speaker 1: substance that kind of tells the testes to produce testosterone.
- 16:03Speaker 1: If you have a tumor in your protuitary or you
- 16:05Speaker 1: had a stroke in a certain place, that's preventing that
- 16:07Speaker 1: from happening. Just the testes just won't produce testosterone. They're
- 16:12Speaker 1: not getting the message from the brain to do it.
- 16:14Speaker 1: Those are the only FDA approved indications, and less than
- 16:18Speaker 1: one percent of men with low testosterone have one of
- 16:23Speaker 1: those indications. So virtually everyone getting testosterone replacement therapy that
- 16:27Speaker 1: you hear about is technically getting it. Off label, which
- 16:29Speaker 1: is fine, it is legal to get drugs off label,
- 16:33Speaker 1: but I think it does lead to the question of, like, Okay,
- 16:36Speaker 1: why isn't there an FDA approval for age related low testosterone,
- 16:42Speaker 1: which is just the fact that testosterone slowly goes down
- 16:45Speaker 1: when you're aging. Caveat RFK Junior has said he wants
- 16:48Speaker 1: there the FDA to investigate this and maybe there will
- 16:50Speaker 1: be an improval in the future. So I think that's
- 16:53Speaker 1: where we kind of have to start, is like, what's
- 16:55Speaker 1: going on with testosterone in the life cycle? And it
- 16:59Speaker 1: is it is their menopause, right, Is there such a
- 17:02Speaker 1: thing isopause?
- 17:05Speaker 2: Is there a menopause? Okay, so so yeah, let's start there.
- 17:08Speaker 2: So let's start with how testosterone moves over the life cycle.
- 17:11Speaker 2: And if you look at a graph, and I think
- 17:14Speaker 2: I'm looking at the end. HAYNES, which is the National
- 17:18Speaker 2: Health and Nutrition Examination Survey, is a nationally representative survey
- 17:23Speaker 2: that the CDC runs. It's a really good source for
- 17:25Speaker 2: a lot of the biometrics that we have no value
- 17:29Speaker 2: over time because exactly like they they unlike many other surveys,
- 17:34Speaker 2: they actually test people. They bring them into these like
- 17:37Speaker 2: like drive around these mobile clinics and participants like come
- 17:40Speaker 2: to the clinic and have their blood drawn anyway, So
- 17:43Speaker 2: this will show you testosterone over the life cycle. And
- 17:47Speaker 2: there is one really striking thing in these graphs which
- 17:52Speaker 2: I'm looking at as we talk, which is, you know,
- 17:55Speaker 2: between the ages of like six and you know twenty,
- 18:00Speaker 2: your testosterone goes from more or less zero.
- 18:04Speaker 3: To like five hundred. And this is like in what
- 18:07Speaker 3: is it?
- 18:07Speaker 2: Is it nanograms for nanogrator for testolator. So at any rate,
- 18:13Speaker 2: you start with none, little kids have very little testosterone,
- 18:16Speaker 2: and then you go up a.
- 18:17Speaker 3: Lot during the period of puberty.
- 18:19Speaker 2: So it's very clear testosterone is very important for driving
- 18:23Speaker 2: the changes that we see in boys during puberty, the
- 18:26Speaker 2: development of secondary sex characteristics, the starting of supermato genesis,
- 18:31Speaker 2: et cetera. And then you see it over time. And honestly, Perry,
- 18:37Speaker 2: I'm looking at this graph and.
- 18:39Speaker 1: I knew you were going to say that when I
- 18:41Speaker 1: put the graph in our in our research document. Yeah,
- 18:45Speaker 1: you sort of. So this graph shows the uh sort
- 18:51Speaker 1: of variation in testosterone levels. And let's just put some
- 18:53Speaker 1: numbers on it because we'll kind of keep coming back
- 18:55Speaker 1: to this in adult males. So post pubescent males. Most
- 19:00Speaker 1: values tend to run between three hundred nanograms pertest leader
- 19:03Speaker 1: and one thousand. Most people would draw the line at
- 19:07Speaker 1: three hundred nanograms per test leader to be like low
- 19:10Speaker 1: testosterone or like lower testosterone. There is no cliff. This
- 19:15Speaker 1: is not estrogen for women going through menopause, which is
- 19:19Speaker 1: kind of up there, and just like tanks at menopause,
- 19:24Speaker 1: it is relatively flat. Now, if you mathematically model this
- 19:28Speaker 1: and account for things, and you know, you can show
- 19:32Speaker 1: in a large enough population that there is an age
- 19:35Speaker 1: related decline in testosterone on average, this is the same
- 19:40Speaker 1: and hates data using mathematical modeling, that kind of average
- 19:43Speaker 1: goes from about four hundred nanograms per test leader at
- 19:46Speaker 1: age twenty to about three hundred nanograms pertest at age eighty.
- 19:52Speaker 1: That's a change, but it's not dramatic.
- 19:56Speaker 2: So manopause, I just have to say, looking at this graph,
- 20:00Speaker 2: and this graph is so obviously this is like we
- 20:04Speaker 2: might need to take this out of the podcast, but
- 20:05Speaker 2: this graph is so obviously driven by somebody overfitting a
- 20:09Speaker 2: line to a very small amount of data on old
- 20:12Speaker 2: people that I can't even much confidence.
- 20:14Speaker 1: Interval.
- 20:15Speaker 3: For those of you who love and overfit. This graph is.
- 20:17Speaker 1: An Emily's not convinced. Okay, Emily's not convinced. How about
- 20:21Speaker 1: this data does suggest across multiple populations, both in the
- 20:26Speaker 1: US and abroad, that average testosterone levels in the population
- 20:32Speaker 1: have decreased over time. So not only as we've gotten older,
- 20:36Speaker 1: but like a fifty year old man today has a
- 20:39Speaker 1: lower testosterone than a fifty year old man in nineteen eighty.
- 20:43Speaker 1: Levels have been going down, they say by about one
- 20:45Speaker 1: percent per year, depends how you model it. Do you
- 20:47Speaker 1: buy that?
- 20:49Speaker 3: Yeah?
- 20:50Speaker 2: I think that's interesting and we should come and we
- 20:51Speaker 2: should come back to it, because I think it's part
- 20:54Speaker 2: of understanding why this has has declined. But I would say,
- 20:58Speaker 2: first if we ask the question like, are is this
- 21:01Speaker 2: like estrogen relative to estrogen where we talked about, there's
- 21:04Speaker 2: really this period in which it declines quite a lot
- 21:06Speaker 2: in which replacement is helpful.
- 21:08Speaker 3: We just we're not seeing that in testosterone.
- 21:09Speaker 2: So it doesn't necessarily mean you wouldn't get something from supplementation,
- 21:13Speaker 2: but it doesn't. It's not the case that there's some
- 21:15Speaker 2: period of your life when you're testosterone is just tanking.
- 21:18Speaker 1: That's right. You can be an eighty year old man
- 21:20Speaker 1: and have a testosterone level that a thirty year old
- 21:22Speaker 1: man has. But like, I challenge you to find an
- 21:25Speaker 1: eighty year old woman not on estrogen supplementation that has
- 21:28Speaker 1: an estrogen level of a thirty year old woman like that,
- 21:30Speaker 1: that does not happen.
- 21:32Speaker 2: Okay, So, but we also know from this amazing enhance
- 21:35Speaker 2: graph that there is a lot of variation within age. Right,
- 21:40Speaker 2: So if you look at like the tenth percentile of people,
- 21:43Speaker 2: say at forty to forty nine, they're at about two hundred,
- 21:47Speaker 2: Then ninetieth percentile is at about I don't know, six
- 21:50Speaker 2: to seven hundred, and so that's a really big range.
- 21:54Speaker 2: And I think that relates to the question of, like
- 21:57Speaker 2: what determines this? How do you get to be a
- 22:00Speaker 2: person of a testosterone level of seven hundred and realistically,
- 22:05Speaker 2: and I'm just going to channel the influencers here, how
- 22:08Speaker 2: do I get the seven hundred? What do I need
- 22:10Speaker 2: to do to optimize my testosterone? Parry, not me specifically,
- 22:15Speaker 2: I have only a small amount of time.
- 22:18Speaker 3: What do you need to do? What are you doing?
- 22:20Speaker 3: What do I need, Ferry to optimize your testosterone?
- 22:22Speaker 1: Yeah, And I mean they're like, all, I think.
- 22:26Speaker 3: You're not doing anything.
- 22:30Speaker 1: I'm actually not doing anything, but I'll give you some
- 22:32Speaker 1: things that you can do to optimize yourself. Or let
- 22:35Speaker 1: me let me phrase it this way. I will say
- 22:39Speaker 1: that before we decide whether we should make some number higher,
- 22:43Speaker 1: we should decide whether it matters to make that number higher.
- 22:47Speaker 1: But because we just talked about variation, I will tell
- 22:51Speaker 1: you what we know what correlates with lower levels versus
- 22:53Speaker 1: higher levels in the general population. Age is one. It's
- 22:57Speaker 1: not as powerful as you think, right, but there is
- 23:01Speaker 1: a statistically significant correlation between age. A history of smoking
- 23:06Speaker 1: lower's testosterone. Current smoking, which is really interesting, will actually
- 23:11Speaker 1: increase your total testosterone level by and this actually might
- 23:17Speaker 1: explain why total testosterone levels have gone down over time.
- 23:20Speaker 1: Can I detour for a second, because this is very weird. Okay,
- 23:24Speaker 1: So testosterone is broken down very quickly in the blood,
- 23:27Speaker 1: has a half life about ten minutes to maybe sixty
- 23:31Speaker 1: minutes depending, So it's carried around the blood by a
- 23:34Speaker 1: chaperone protein called sex hormone binding globulin, and that kind
- 23:38Speaker 1: of protects it. It like wraps testosterone in a little
- 23:40Speaker 1: hug and you know, keeps it safe from being degraded.
- 23:43Speaker 1: But it's also an active testosterone in that bound form
- 23:46Speaker 1: can't do anything. It has to be free. Free testosterone
- 23:50Speaker 1: is the active form that's about two percent of total testosterone.
- 23:53Speaker 1: But most people, if you're getting your lab test measured,
- 23:56Speaker 1: and all the numbers we've said so far are total
- 23:58Speaker 1: testosterone numbers, because free testosterone is a very difficult test
- 24:02Speaker 1: to run. It's expensive. There's a couple different essays, none
- 24:05Speaker 1: of them are FDA cleared at this point in time,
- 24:09Speaker 1: so most people are getting total testosterone. If you increase
- 24:12Speaker 1: sex hormone binding globulin, you'll increase total testosterone because you
- 24:16Speaker 1: just kind of have more that's out there stuck to
- 24:18Speaker 1: the chaperone protein, but it's not actually doing anything, and
- 24:22Speaker 1: current smoking does that. So there is some possibility that
- 24:27Speaker 1: the reason we see this generational decline in total testosterone
- 24:32Speaker 1: is actually because we're smoking less, which is a really
- 24:37Speaker 1: sort of paradoxical and fascinating finding.
- 24:39Speaker 2: Why would having a history of smoking make your testosterone lower.
- 24:43Speaker 1: I think that's just comorbidities. So the other stuff on
- 24:46Speaker 1: the list for making your testosterone lower is like higher BMI, depression, diabetes,
- 24:54Speaker 1: These are all things that kind of go along with smoke. Obviously, cancer,
- 24:57Speaker 1: right so I think the history of smoking is just
- 25:00Speaker 1: like you've kind of if you put your body through
- 25:01Speaker 1: the ringer. Testosterone also is a hormone that has a
- 25:05Speaker 1: pretty fascinating response to your psychosocial state. So there's a
- 25:11Speaker 1: well studied phenomenon that if a man wins something, their
- 25:17Speaker 1: testosterone level goes up. So if you like measure you
- 25:20Speaker 1: know soccer players before the championship game and you do
- 25:22Speaker 1: their their salary testosterone and then you you know, one
- 25:26Speaker 1: team wins, one team loses, the winning team will have
- 25:29Speaker 1: a significantly higher testosterone after the game. This doesn't last
- 25:32Speaker 1: for very long. This also carries over to men watching
- 25:35Speaker 1: their favorite sports teams. So if you are, you know,
- 25:40Speaker 1: an Eagles fan, Jalen Hurts runs it in for a touchdown,
- 25:45Speaker 1: your testosterone might go up a little bit. So it is.
- 25:47Speaker 1: It is quite a cerebral thing, don't you think.
- 25:50Speaker 3: That's a that?
- 25:51Speaker 2: I mean that feels like an evolutionary adaptation, right, which
- 25:53Speaker 2: is like the moment that I win the fight with
- 25:55Speaker 2: the other guy, that's the moment, and that a lot
- 25:58Speaker 2: of the lady animals, the lady monkeys want to have
- 26:02Speaker 2: sex with me, and so I want to be like
- 26:03Speaker 2: in a high like tsostne environment. So I'm like ready
- 26:07Speaker 2: for the lady monkeys after the soccer game.
- 26:09Speaker 1: I mean, yeah, I'll buy it. I'll totally buy me.
- 26:11Speaker 1: I don't know, I'm not an evolutionary biologist.
- 26:13Speaker 2: Makes sense, right, I know, But I think evolutionary bology
- 26:15Speaker 2: is just like telling stories like that, just some of it,
- 26:18Speaker 2: some of it, some hypothesis generation. There is that kind
- 26:20Speaker 2: of story, and I've asked the story I'm going with.
- 26:24Speaker 1: I totally love it.
- 26:25Speaker 3: Did you lose your trade of thought?
- 26:27Speaker 1: No, of course not, because I have one other thing
- 26:29Speaker 1: that has been shown to temporarily increase testosterone, which is
- 26:33Speaker 1: watching erotica or sexually charged visual imagery. Men are simple creatures, Emily.
- 26:40Speaker 2: You like to win soccer and watch porns, and those
- 26:42Speaker 2: are the activities that you enjoy.
- 26:44Speaker 1: As I was reading about this and comparing it to
- 26:46Speaker 1: like estrogen and women, and it's like so complicated and
- 26:49Speaker 1: like how you know what's what's going on? Men?
- 26:51Speaker 3: Soccer and porn?
- 26:53Speaker 1: Things we like, yeat, that's it doesn't take much. So
- 26:58Speaker 1: but but there is a lot of between person variation
- 27:02Speaker 1: and testosterone, and there is also within person variation in testosterone. Emily.
- 27:08Speaker 1: One of the things that came out when I was
- 27:11Speaker 1: looking at like how testosterone is measured, is this fact
- 27:15Speaker 1: that the coefficient of variation of testosterone measurement is fifty
- 27:19Speaker 1: percent or higher within a man. Can you, with your
- 27:23Speaker 1: data hat on, explain what coefficient of variation means?
- 27:27Speaker 3: So a coefficient of variation is it?
- 27:30Speaker 2: Technically it's the ratio of the standard aviation to the mean,
- 27:34Speaker 2: which is not that.
- 27:34Speaker 3: Helpful for people.
- 27:36Speaker 2: It's really a way to measure sort of how much
- 27:40Speaker 2: something is varying, in this case within a person scaled
- 27:45Speaker 2: to the means. So if something has a coefficient of
- 27:47Speaker 2: variation of fifty percent, it varies quite a lot within
- 27:54Speaker 2: a person over time. You know, many things would have
- 27:57Speaker 2: like you know, your weight within a time for does
- 28:00Speaker 2: not have a coefficient variation anything like that exactly.
- 28:03Speaker 1: And so you know, just to put like a number
- 28:05Speaker 1: on it, roughly, we could say, like, okay, if you're
- 28:08Speaker 1: testosterone is kind of on average is three hundred, you
- 28:11Speaker 1: get it measured one day, maybe it's four fifty, right,
- 28:15Speaker 1: maybe it's one fifty another day. Let me play you
- 28:19Speaker 1: an influencer that I think speaks to this potential problem
- 28:24Speaker 1: with testing.
- 28:25Speaker 4: I increase my testosterone by forty eight percent and only
- 28:28Speaker 4: twenty one days without medication.
- 28:30Speaker 1: Heer's out. I'm not even going to tell you.
- 28:32Speaker 3: How is it that he tested again? Thought right?
- 28:35Speaker 1: So that's the thing I want to get out. When
- 28:38Speaker 1: someone says, you know, my, my, whatever it is, my
- 28:40Speaker 1: testosterone might anything that went up dramatically, you have to
- 28:45Speaker 1: know how variable it is at baseline, and testosterone is
- 28:48Speaker 1: highly variable. We know for one thing. For example, it's
- 28:51Speaker 1: about fifteen percent higher on average in the morning than
- 28:54Speaker 1: in the afternoon. So like men's testosterone is just higher.
- 28:58Speaker 1: But that's like averaging a cross thousands of men within
- 29:02Speaker 1: a given man. If you test today and you test
- 29:04Speaker 1: a week from now, you're going to get very different numbers.
- 29:08Speaker 1: And that is going to have the effect because we're
- 29:10Speaker 1: all human, that you will start to assign causality to
- 29:16Speaker 1: things that you did to make that change when there
- 29:19Speaker 1: is in fact nothing. The recommendation from endochronologists is in
- 29:23Speaker 1: fact that you don't diagnose low testosterone without at least
- 29:27Speaker 1: two measurements temporarily separated that are both below three hundred
- 29:32Speaker 1: nanograms pertestlaer.
- 29:34Speaker 2: So one of the reasons to keep I mean, I
- 29:35Speaker 2: think that that influencer clip is you know, it's interesting
- 29:40Speaker 2: from the coefficient a variation standpoint, but it's also interesting
- 29:42Speaker 2: because of course this guy's on the internet saying how
- 29:45Speaker 2: great is testosteronis And that's like as a marker of
- 29:49Speaker 2: you know whatever, positive of manhood presumably, which gets to
- 29:55Speaker 2: the question of whether, in fact we see like are
- 29:59Speaker 2: the a symptoms of low testosterone either low or just intermediate?
- 30:04Speaker 2: Like if you told me I've been tested many times
- 30:07Speaker 2: at my testosterone level is five hundred, should I expect
- 30:11Speaker 2: you to be better on some dimension than if your
- 30:14Speaker 2: testosterone is four hundred?
- 30:15Speaker 1: Yeah, that's my guys, This is the question, okay, because
- 30:19Speaker 1: we're so tempted to look at numbers and be like,
- 30:23Speaker 1: higher number is better. And we do this with so
- 30:26Speaker 1: many things, right, We do this with like vitamins, we
- 30:28Speaker 1: do it with protein to some extent, right, Like we're
- 30:31Speaker 1: trying to max everything. Let me let me play another
- 30:34Speaker 1: influencer clip.
- 30:35Speaker 5: I'm ready, Oh, man, is normal in a three hundred
- 30:38Speaker 5: testosterone range? Your quality of life is gone. And it's
- 30:41Speaker 5: like you said, it's not just libido. You're not gonna
- 30:44Speaker 5: be able to lose weight, You're not gonna be able
- 30:46Speaker 5: to gain muscle. Just like you just said, you're gonna
- 30:49Speaker 5: be feeling like you can't focus on anything, brain fog
- 30:53Speaker 5: like to no end. You're also gonna ach. You know
- 30:56Speaker 5: that you're gonna ache, You're not gonna be able to
- 30:58Speaker 5: move well, every little thing you do going to hurt.
- 31:00Speaker 1: It's going to be painful. That sounds sounds terribly, It
- 31:06Speaker 1: sounds pretty bad. I don't want to have a testosterone
- 31:09Speaker 1: level below three hundred, so how but is it actually true?
- 31:17Speaker 1: Let's walk through the EMASS study from the New England
- 31:20Speaker 1: Journal of Medicine, because I think this is the one.
- 31:23Speaker 1: This is like how you would design a study to
- 31:26Speaker 1: assess what the effects of differing levels of testosterone are.
- 31:31Speaker 1: So, so this was a survey based study three three hundred
- 31:35Speaker 1: and sixty nine men ages forty to seventy nine in Europe,
- 31:38Speaker 1: and they gave them very long questionnaires asking about a
- 31:42Speaker 1: wide variety of symptoms depression, confusion, brain fog, fatigue, sexual symptoms,
- 31:51Speaker 1: on and on and on. After giving them all those questionnaires,
- 31:55Speaker 1: they measured their testosterone level. Right, and this is what
- 31:57Speaker 1: you would.
- 31:58Speaker 3: Want using like for real, using a blood test.
- 32:01Speaker 1: Yeah, so it's like, okay, this is you know, it's
- 32:04Speaker 1: one thing to say, like I measured my testosterone and
- 32:08Speaker 1: it was two hundred and fifty, and now I attribute
- 32:11Speaker 1: everything that's bad in my life to that to that number.
- 32:14Speaker 1: That's sort of like astrology, right, It's like it's like
- 32:16Speaker 1: I'm a Libra and like, so that's why you can't
- 32:18Speaker 1: trust me or whatever. I Actually, I don't know is
- 32:19Speaker 1: that true about Libra's.
- 32:20Speaker 3: I couldn't listeners? Not really my thing.
- 32:24Speaker 1: That's probably because you're a virgo.
- 32:27Speaker 3: I'm gonnaquarius.
- 32:28Speaker 1: Okay, should have known no with that, Okay. So this
- 32:32Speaker 1: study instead says like, look, there are gonna be people
- 32:35Speaker 1: who have depression, and are there more people who with
- 32:39Speaker 1: depression at a low testosterone or is it just something
- 32:41Speaker 1: that yes, of course people with low testosterone have depression
- 32:44Speaker 1: and people with high testosterone have depression. So, Emily, was
- 32:48Speaker 1: there anything that stood out to you and the results
- 32:50Speaker 1: of this study as like, what if anything? Is it
- 32:54Speaker 1: clear that lower testosterone causes symptom logically symptomatically?
- 33:00Speaker 2: So the statistics in this study are a little like
- 33:04Speaker 2: a little tortured for the sort of basic reason that
- 33:08Speaker 2: they're doing a tremendous number of different tests and running
- 33:11Speaker 2: them in various ways, so the like sort of some
- 33:14Speaker 2: of the key results that show up as significant. They're
- 33:17Speaker 2: kind of picking a threshold and then estimating the impact
- 33:20Speaker 2: as you sort of move below that that threshold. But
- 33:24Speaker 2: of course there's a tremendous amount of choice that goes
- 33:27Speaker 2: into like, well what is the threshold and exactly how
- 33:30Speaker 2: do you structure it? And if you're kind of like,
- 33:33Speaker 2: you know, messing messing around, you can get closer to significance.
- 33:37Speaker 3: And they're testing many things.
- 33:39Speaker 2: I will say, the thing that sort of shows up
- 33:43Speaker 2: most consistently here.
- 33:45Speaker 3: Is stuff about sex.
- 33:46Speaker 2: So sexual thoughts, mourning, erections, erectile dysfunction, those are the
- 33:53Speaker 2: key things. The effects are not that big, right, So
- 33:58Speaker 2: like it's a little hard to exactly translate their number
- 34:02Speaker 2: into something that would be meaningful for a person. So
- 34:05Speaker 2: it's like what's the odds ratio when you move one
- 34:08Speaker 2: animal per leader below the threshold?
- 34:10Speaker 3: Who knows what that number means? But the effects are
- 34:13Speaker 3: small and not very significant, is my read?
- 34:17Speaker 1: Yeah, I mean even it's very hard to actually assign
- 34:20Speaker 1: like good numbers to decrease sexual thoughts, right, It's like,
- 34:24Speaker 1: what how often you thinking about sex? Like there's all
- 34:27Speaker 1: those sort of urban legends and stuff like that. But yes,
- 34:29Speaker 1: to me, it's very clear they looked at, you know,
- 34:32Speaker 1: fifty different potential symptoms and the only things that sort
- 34:34Speaker 1: of withstood, however, torture, the statistics are the only things
- 34:38Speaker 1: that sort of stood out were things about sex. So yes,
- 34:42Speaker 1: it does seem like if your testosterone is lower, your
- 34:46Speaker 1: sex drive and things associated with sex drive is going
- 34:49Speaker 1: to be lower. But notably, the psychological symptoms had no
- 34:52Speaker 1: correlation with testosterone level. So these influencers who are like, oh,
- 34:55Speaker 1: if you're below three hundred, you're going to be essentially
- 34:58Speaker 1: on your deathbed. You're going to be in pain, and
- 35:00Speaker 1: you're going to be depressed, you can't think straight, you
- 35:02Speaker 1: have no energy, Like that is not born out in
- 35:05Speaker 1: the data where people are blinded to their testosterone level, right,
- 35:10Speaker 1: Like you can you can make the argument after the fact,
- 35:13Speaker 1: you can kind of attribute it, but you're probably incorrect.
- 35:16Speaker 3: Yeah.
- 35:16Speaker 2: I think the other thing about this trial and even
- 35:18Speaker 2: about these results is what they're looking at is sort
- 35:21Speaker 2: of what is happening as you're moving down below some
- 35:23Speaker 2: lower threshold. Right, So here we're like really very focused
- 35:26Speaker 2: on this question of if you are like these influencers saying, okay,
- 35:30Speaker 2: if you're below three hundred, what happens to you? Again,
- 35:33Speaker 2: there's no cliff But most of these trials are about
- 35:37Speaker 2: these lower like moving down within lower levels, not asking
- 35:43Speaker 2: the question of whether seven.
- 35:44Speaker 3: Hundred is better than six hundred.
- 35:47Speaker 2: And oh yeah, And for that I think we just
- 35:49Speaker 2: have no there's no evidence to suggest that's true.
- 35:52Speaker 1: Yeah, and I would be very honestly, I'd be very
- 35:53Speaker 1: surprised if it's true. And the variation within a person.
- 35:56Speaker 1: You know, if you're below seven hundred, if you're six
- 35:58Speaker 1: fifty today, you're seven fifty tomorrow, you're six hundred the
- 36:01Speaker 1: next day. Like, you know, you're only going to see
- 36:04Speaker 1: effects when things are low. And again it looks like
- 36:07Speaker 1: those effects are are fairly limited. But that was an
- 36:11Speaker 1: observational study, right, that didn't say anything about replacing testosterone.
- 36:15Speaker 1: So there's okay, if you don't have enough testosterone, all right,
- 36:20Speaker 1: you have decreased morning erections and a higher risk of
- 36:22Speaker 1: rectile dysfunction. Then the question is, okay, what if we
- 36:26Speaker 1: replace testosterone, do those things get better? Do other things
- 36:29Speaker 1: get better too? And in this case, we really don't
- 36:34Speaker 1: want influencers to tell us what their anecdotal experience was.
- 36:40Speaker 1: We want to hear in the form of randomized trials, right,
- 36:43Speaker 1: we want placebo controls where people don't know they're getting testosterone,
- 36:46Speaker 1: because we've said a million times, if I tell you,
- 36:49Speaker 1: I'm giving you testosterone, even if it's not, it's like
- 36:52Speaker 1: Felix fellicis in Harry Potter, right, You're just like you
- 36:56Speaker 1: feel good, and that's the power of place ebah.
- 36:59Speaker 2: And this is such a a classic place where the
- 37:01Speaker 2: placebo effect is going to matter, Yeah, tremendously because if
- 37:06Speaker 2: you tell somebody you know, I'm giving you something and
- 37:08Speaker 2: it's going to make you feel more excited about sex,
- 37:11Speaker 2: Like they are going.
- 37:12Speaker 3: To feel more excited about sex for sure. There's just
- 37:14Speaker 3: like no question. So much of this is in your head.
- 37:17Speaker 1: Yeah, yeah, yeah, that's how oysters work. So let's we
- 37:22Speaker 1: can't obviously talk about every trial, but I think there's
- 37:24Speaker 1: a couple that are are relevant to the discussion. The
- 37:27Speaker 1: testosterone trials. The te trials enrolled seven hundred and eighty
- 37:31Speaker 1: eight men above age sixty five who had total testosterone
- 37:34Speaker 1: less than to seventy five.
- 37:35Speaker 2: Can I just ask you before we get into the like,
- 37:37Speaker 2: what do you think about focusing only on old, older
- 37:40Speaker 2: men in this, do you wish that they had focused
- 37:43Speaker 2: also on people like you?
- 37:45Speaker 1: I think they would not find the signals that they want.
- 37:48Speaker 1: I think it would be very expensive. So you know,
- 37:50Speaker 1: the truth is, if you're enrolling people with normal testosterone levels,
- 37:55Speaker 1: you're not going to get any signal with physiological levels
- 37:58Speaker 1: of replacement. By the way, knows right that like antabolic
- 38:01Speaker 1: steroids that bodybuilders use are testosterone, right, or synthetic forms
- 38:05Speaker 1: of testosterone. People know that.
- 38:06Speaker 2: Yeah, I'm not sure if people know that, let's tell
- 38:09Speaker 2: them that anabolic steroids or a synthetic form of testosterone.
- 38:11Speaker 1: Yeah, they just happen to be given in like ten
- 38:14Speaker 1: times the dose of testosterone placement therapy, or even up
- 38:17Speaker 1: to like thirty times the dose. So these are crazy,
- 38:19Speaker 1: super physiologic doses of testosterone. And I think, in fact,
- 38:23Speaker 1: some of the hesitancy to get to your point, Emily
- 38:26Speaker 1: about testing and giving men testosteronal replacement therapy comes from
- 38:30Speaker 1: the complications that have been seen in bodybuilders, because we
- 38:33Speaker 1: know that when you're giving ten times the normal rate
- 38:35Speaker 1: of testosterone, you get infertility, liver failure, roid rage, baldness,
- 38:42Speaker 1: cardiovascular disease. Like all this bad stuff happens. But just
- 38:46Speaker 1: because that happens at ten x the dose doesn't necessarily
- 38:50Speaker 1: means it happens at one x the dose, right, like
- 38:52Speaker 1: like the dose is the poison, as the toxicologists like
- 38:55Speaker 1: to say. So I think that has you know, actually
- 38:57Speaker 1: hampered this research a little bit.
- 38:58Speaker 2: All right to getting back to this TESASA trials with
- 39:00Speaker 2: the older the older men, these focus on people who
- 39:05Speaker 2: have testosterone in lower levels. So I think the criteria
- 39:09Speaker 2: here was below two hundred and seventy five, So people
- 39:12Speaker 2: who were in the range of the you know, below
- 39:14Speaker 2: three hundred and you're basically dead.
- 39:18Speaker 3: And what happens.
- 39:20Speaker 1: What happens is your sexual stuff gets better. So these
- 39:24Speaker 1: older men that were randomizing, again placebo controlled randomized to
- 39:27Speaker 1: testosterone had a forty percent increase in sexual activity sexual
- 39:31Speaker 1: activity frequency, a twenty five percent increase in their libido scores,
- 39:35Speaker 1: and a thirty five percent improvement in a rectile function,
- 39:38Speaker 1: but no improvement in vitality or energy, and only very
- 39:42Speaker 1: small improvements in mood and walking distance. And this is
- 39:46Speaker 1: something that like gets repeated. I've seen this again and again,
- 39:51Speaker 1: Like if you look really at if you ignore the
- 39:54Speaker 1: influencers who say I started taking testosterone in placement therapy
- 39:57Speaker 1: and everything was a miracle. What you hear from men
- 40:00Speaker 1: is like sex sex sex. I am. I looked at
- 40:04Speaker 1: a Reddit thread in.
- 40:05Speaker 3: The ask Matrimonia.
- 40:06Speaker 1: It's a sex serment. Okay, there's a great reddit thread
- 40:11Speaker 1: in the ask Men's subreddit. It was like anyone taking
- 40:13Speaker 1: testosterone placement therapy, like, how was it for you? And
- 40:16Speaker 1: the basic breakdown is like twenty percent of people being like,
- 40:20Speaker 1: I took it, and actually I didn't feel much. Twenty
- 40:23Speaker 1: percent of people are like, I took it. My life
- 40:26Speaker 1: is great now, like I feel so much more energy,
- 40:28Speaker 1: I feel young again, great, And sixty percent of people
- 40:32Speaker 1: are exclusively talking about like the quality of their erections
- 40:39Speaker 1: and how horny they are, with one amazing comment blaming
- 40:44Speaker 1: testosterone replacement therapy for the failure of his marriage because.
- 40:49Speaker 3: He wanted more sex than she didn't.
- 40:51Speaker 1: Exactly. Yeah, something that that has has come up on
- 40:56Speaker 1: this odd podcast before. Emily has suggested that, you know,
- 40:59Speaker 1: women have a lower sex drive than men. And I
- 41:02Speaker 1: tried to be offended and I couldn't. And the data
- 41:05Speaker 1: tends to bear Emily out.
- 41:06Speaker 3: Data shows, data shows so be.
- 41:08Speaker 1: Careful if you're taking testoster replacement or you might want
- 41:11Speaker 1: to discuss it with your significant other.
- 41:13Speaker 3: You should always talk about this stuff.
- 41:15Speaker 2: Yeah, yeah, I mean, I think in a look when
- 41:16Speaker 2: you look the picture here feels very clear and almost
- 41:23Speaker 2: it's an example where you're in this rabbit hole of
- 41:26Speaker 2: influencers and if you just pull yourself out and you're like, Okay,
- 41:30Speaker 2: let me just think about, like what is likely to
- 41:33Speaker 2: be true based on what we know about this.
- 41:35Speaker 3: It seems likely that the thing that is going to
- 41:38Speaker 3: happen is about.
- 41:39Speaker 2: Sex, because that is and about feelings about sex, because
- 41:42Speaker 2: that is like the core.
- 41:45Speaker 3: Thing about disosterone is that.
- 41:47Speaker 2: It has all these things to do with how you
- 41:50Speaker 2: feel about sex and how much you want to have sex,
- 41:52Speaker 2: and your ability to have sex and all these other
- 41:54Speaker 2: all these other pieces. Just like it feels like that
- 41:56Speaker 2: is very sensible in contrast to a claim like you
- 42:00Speaker 2: won't be able to walk or move very well, which
- 42:05Speaker 2: is really no reason to think testosterone would have anything
- 42:07Speaker 2: to particular to do with.
- 42:09Speaker 1: Yeah, and I mean, insofar as mood maybe does improve slightly,
- 42:15Speaker 1: Like we can even draw a line between the sexual
- 42:18Speaker 1: effects and those subjective effects on mood and energy, and whatnot.
- 42:24Speaker 1: I mean, maybe not for the guy whose whole marriage
- 42:26Speaker 1: fell apart because of sexual incompatibility, but you can certainly
- 42:31Speaker 1: imagine that if all you do is increase sex drive,
- 42:34Speaker 1: like for many men, that might be enough to feel
- 42:38Speaker 1: a little bit better about things.
- 42:39Speaker 2: Right, totally, So if people are not interested in taking
- 42:45Speaker 2: exogenous testosterone, I mean, there are a couple of places
- 42:49Speaker 2: where it seems like there are small impacts of lifestyle
- 42:53Speaker 2: changes on testosterone, mainly around weight loss, is what I
- 42:56Speaker 2: would say, Like, there is some evidence of small all
- 43:00Speaker 2: amounts of increases in testosterone as a result of weight loss,
- 43:03Speaker 2: and similar with you know, GLP ones, which is presumably
- 43:06Speaker 2: for the same for the same reason. Those are again
- 43:09Speaker 2: like those are actually those effects are pretty.
- 43:11Speaker 3: Small, smaller than I might have thought that they would be.
- 43:13Speaker 1: Actually, yeah, me too. We usually see sort of better
- 43:17Speaker 1: effects with significant weight loss in other domains. Yeah, absolutely,
- 43:24Speaker 1: That is actually one of the reasons as I was
- 43:26Speaker 1: kind of looking through this and deciding what my feelings
- 43:28Speaker 1: were about testosterone replacement therapy, I tend to constitutively be like, oh, like,
- 43:33Speaker 1: let's find lifestyle things that can improve the thing first,
- 43:36Speaker 1: rather than just like supplements or you know, doing it exogynously,
- 43:40Speaker 1: And the truth is that there's not a slam dunk here. Again,
- 43:47Speaker 1: you're gonna see some people telling you that, like there's
- 43:50Speaker 1: really easy natural ways to increase your testosterone. Here's here's
- 43:55Speaker 1: a guy talking about zinc.
- 43:57Speaker 4: If your libido is gone and your energy is tank,
- 44:00Speaker 4: you might not have a hormone problem, you have a
- 44:02Speaker 4: zinc problem. Your body cannot build testosterone without zinc. Today
- 44:06Speaker 4: we're libido maxing at Whole Foods.
- 44:10Speaker 1: We're libido maxing. I love it.
- 44:12Speaker 3: Please don't do it at whole food So why I
- 44:14Speaker 3: know whole Foods.
- 44:15Speaker 2: I don't want a bunch of people libido maxing while
- 44:17Speaker 2: I'm just try chaper.
- 44:18Speaker 1: Just to buy the testosterone.
- 44:21Speaker 3: So is that true about the zinc? What what way
- 44:24Speaker 3: is zinc related?
- 44:26Speaker 1: This is like classic mechanism jumping to conclusion problem. So yes,
- 44:31Speaker 1: zinc is a cofactor in the synthesis of testosterone, as
- 44:35Speaker 1: like in the biosynthetic pathway of testosterone you need a
- 44:38Speaker 1: little bit of zinc. That does not mean that getting
- 44:42Speaker 1: your zinc level crazy high increases that. It's like it's
- 44:46Speaker 1: a vitamin, right, or it's a mineral, but like it
- 44:48Speaker 1: you know you need some amount or else you can't
- 44:51Speaker 1: synthesize testosterone, but having more doesn't mean you synthesize more.
- 44:56Speaker 1: About eight percent of the United States is zinc deficient,
- 44:59Speaker 1: but this is lar Argually, people with significant colmorbidities, who
- 45:02Speaker 1: are older and who don't have access to adequate nutrition.
- 45:06Speaker 1: Your you listener are probably not sync deficient, and pumping
- 45:10Speaker 1: up your zinc levels not going to really increase your testosterone,
- 45:12Speaker 1: although again, if you check it a couple times, you're
- 45:14Speaker 1: going to get numbers you like. It's like taking the
- 45:16Speaker 1: SATs over and over again.
- 45:17Speaker 2: Really, I was just thinking, it's like, and take it again, right,
- 45:19Speaker 2: they only count one of.
- 45:20Speaker 1: Them, and I will say that the more. If your
- 45:22Speaker 1: zinc is too high, then your copper metabolism can get
- 45:26Speaker 1: thrown off and maybe you don't get enough copper. I
- 45:28Speaker 1: don't know, So don't don't stress about stuff like that.
- 45:32Speaker 1: I think the real question for people when they're considering
- 45:34Speaker 1: testosterone real placement therapy is really quite simple. Is is
- 45:38Speaker 1: my indogenous testosterone low? And is it really low? Like
- 45:41Speaker 1: is not? Did I get one value that was low
- 45:43Speaker 1: and all the others are normal.
- 45:44Speaker 3: Consistently below three hundred on multiple tests.
- 45:47Speaker 1: And do I have sexual symptoms? Yeah, And if the
- 45:50Speaker 1: answer to either of those is no, like there's not
- 45:53Speaker 1: much to be done.
- 45:54Speaker 2: I'm going to add to the to the last thing,
- 45:56Speaker 2: like do I have sexual symptoms that are a problem
- 45:59Speaker 2: for me? Because I think actually, when we talk about
- 46:01Speaker 2: sex here, it's like, you know, we're always talking about this,
- 46:05Speaker 2: like your goal is to want more sex, and like
- 46:08Speaker 2: maybe that is that is your goal or I'm being
- 46:09Speaker 2: bothered by not having.
- 46:11Speaker 3: The libido that I want.
- 46:12Speaker 2: I think that if that's true, that's absolutely a consideration.
- 46:15Speaker 2: I think people should ask always ask a question like
- 46:18Speaker 2: is this something that's actually a problem or.
- 46:21Speaker 1: Yeah not yeah, yeah, yeah, very important.
- 46:25Speaker 2: What about risks here at the kind of dosage levels
- 46:29Speaker 2: So we see, obviously at very high dose levels like
- 46:32Speaker 2: you would have in an anomolic steroid, there are many
- 46:37Speaker 2: issues acne, weird hair in different places, or not enough hair.
- 46:43Speaker 1: Strokes and heart attacks, strokes and heart attacks, liver failure.
- 46:46Speaker 2: Being caught by USADA for doping. But what about for
- 46:50Speaker 2: people outside of this in a normal dose.
- 46:54Speaker 1: Yeah, I mean, the major concern has always been cardiovascular disease. Again,
- 46:58Speaker 1: I think largely driven by the bodybuilding community in fact,
- 47:02Speaker 1: the FDA mandated a trial in higher risk older adults
- 47:06Speaker 1: of testosterone replacement to see This was a trial called
- 47:09Speaker 1: Traverse more than five thousand people randomized trial for testosterone
- 47:14Speaker 1: replacement therapy to look for cardiovascular disease as an important outcome,
- 47:19Speaker 1: and actually there was no difference in major adverse coronary
- 47:22Speaker 1: events in that trial. Again, you'll see influencers like who
- 47:26Speaker 1: are really pushing TRT being like afraid of the cardiovascular
- 47:29Speaker 1: risks the Traverse trial like repudiated this. But you know,
- 47:34Speaker 1: no one trial is perfect. I mean you'll hear Traverse, Traverse, Traverse,
- 47:37Speaker 1: No one trial is perfect. The follow up was thirty
- 47:39Speaker 1: three months in that trial, which is you know, almost
- 47:42Speaker 1: three years. But that doesn't mean that you know, stuff
- 47:46Speaker 1: can be going on that gets you ten years down
- 47:48Speaker 1: the line. And I will say, if you actually dig in,
- 47:51Speaker 1: if you actually if you actually read the Traverse trial,
- 47:54Speaker 1: what you'll find is that there was a higher rate
- 47:58Speaker 1: of atrial fibrillation, which is that abnormal heart rhythm that
- 48:01Speaker 1: actually endurance athletes like yourself, Emily are at higher risk
- 48:05Speaker 1: for thanks and blood clots in the testosterone arm low.
- 48:11Speaker 1: You know, the absolute risk was very low, but it
- 48:13Speaker 1: was higher than in the placebo group. Other risks that
- 48:16Speaker 1: I think are you know, worth considering. One is fertility,
- 48:20Speaker 1: So so testosterone supplementation if you are trying to not
- 48:25Speaker 1: become pregnant, get someone pregnant. If you're trying to get.
- 48:27Speaker 3: Someone pregnant, contribute positively to pregnancy.
- 48:29Speaker 1: Yeah, yeah, testosterone placement can decrease the production of sperm.
- 48:35Speaker 1: There are the issues with acne and hair loss, and
- 48:38Speaker 1: then prostate enlargement, but probably not prostate cancer, so benign
- 48:42Speaker 1: prostatic hypert refuge is just a benign enlargement in the
- 48:44Speaker 1: prostate can make it a little hard to pee. That's
- 48:46Speaker 1: been shown. And then I've got a fun bit of
- 48:48Speaker 1: chemistry for you, which is that testosterone is metabolized in
- 48:54Speaker 1: fat cells to estrogen to a stratiol via a enzyme
- 49:01Speaker 1: called aroma tase. And this is why people on very
- 49:06Speaker 1: high doses of men on high doses of testosterone can
- 49:10Speaker 1: develop kind of camastia, which is the development of like
- 49:12Speaker 1: glandular breast tissue as popularized by Robert Paulson in Fight
- 49:19Speaker 1: Club for the gen Xers, played admirably by meat Loaf.
- 49:24Speaker 1: So there is a risk of gind ofcomasia from testosterone supplementation.
- 49:28Speaker 1: And it is higher if you have a higher body
- 49:31Speaker 1: fat percentage, because that's where that conversion to estrogen takes place.
- 49:37Speaker 2: Okay, I have one last urban legend to discuss before
- 49:41Speaker 2: we smash our pass, which is the ratio of index
- 49:45Speaker 2: to ring finger.
- 49:46Speaker 3: So there's like this idea that if you have a.
- 49:49Speaker 2: Long ring finger, I think it's right that that indicates
- 49:55Speaker 2: a high level of testosterone.
- 49:58Speaker 1: Yeah, this is also all for Instagram. Take a listen.
- 50:01Speaker 6: Your finger length reveals how much testosterone you were exposed
- 50:04Speaker 6: to in the womb. Hold your right hand up. If
- 50:07Speaker 6: your ring finger is longer than your index finger, you
- 50:11Speaker 6: had high prenatal testosterone exposure. Is there the same length,
- 50:16Speaker 6: or your index is longer you had lower exposure. This
- 50:19Speaker 6: ratio is called the two D four D and it's
- 50:22Speaker 6: one of the most studied markers in human biology.
- 50:25Speaker 1: Okay, So, so I don't know that this is one
- 50:28Speaker 1: of the most studied UH mark markers in human biology,
- 50:32Speaker 1: but boy, if I didn't look at my own finger.
- 50:36Speaker 3: Yeah, you your fingers seem like you're in trouble.
- 50:38Speaker 1: Well, I feel like depending on kind of how I
- 50:40Speaker 1: hold my hand, I can kind of make it do
- 50:42Speaker 1: what now? I don't know. Maybe I didn't get enough testosterone.
- 50:45Speaker 1: What does that even mean? This guy goes on, I'm
- 50:47Speaker 1: not playing the whole clip, but he goes it's He
- 50:49Speaker 1: goes on to say, like, oh, then you know, if
- 50:51Speaker 1: you had more testosterone in the womb, you're like gonna
- 50:54Speaker 1: be more aggressive in life. And I don't know, Emily,
- 50:57Speaker 1: you were saying, there's.
- 50:58Speaker 2: Some amount of literature. This is just a bunch of bullshit,
- 51:03Speaker 2: But I like, so I happened. I'm looking at a
- 51:06Speaker 2: meta analysis of this, which here is the key statement.
- 51:09Speaker 2: We found no evidence of the relationship between the testosterone
- 51:12Speaker 2: types and digit ratios.
- 51:15Speaker 3: Furthermore, there was.
- 51:15Speaker 2: No evidence and very so this is uh, there is
- 51:18Speaker 2: no evidence of this. Maybe it is very highly studied,
- 51:21Speaker 2: but very highly studied to conclude that it is fake
- 51:25Speaker 2: that he should have added that he should have like
- 51:26Speaker 2: this is very highly studyed and we've concluded it's garbage.
- 51:29Speaker 1: I mean, even if true, I don't see just like
- 51:31Speaker 1: how this matters aside from I don't know, making conversation
- 51:37Speaker 1: of parties or something.
- 51:38Speaker 3: Okay, Perry, I'm gonna ask you a personal question. Do
- 51:41Speaker 3: you know your tesosterone level? No, you didn't even test
- 51:44Speaker 3: it for this episode.
- 51:46Speaker 2: I did.
- 51:46Speaker 1: I don't how much. I don't have what I know?
- 51:50Speaker 3: I know my testosterone.
- 51:51Speaker 1: Oh what's your testosterone?
- 51:52Speaker 3: Twenty five? Okay, it's like it's not it's below three hundred.
- 51:56Speaker 3: But yeah, I don't know. It's part of this blood panel,
- 51:59Speaker 3: part of some blood panel I've got. I don't know.
- 52:01Speaker 3: It said it was sufficient.
- 52:03Speaker 1: That seems that seems entirely normal.
- 52:05Speaker 3: Sufficient.
- 52:06Speaker 1: It would be low for me. No, I mean, I
- 52:09Speaker 1: haven't had it tested. It's one of those things where
- 52:13Speaker 1: I don't have symptoms that I would attribute to low testosterone.
- 52:16Speaker 1: And so even if I had it tested and it
- 52:19Speaker 1: was low, I don't know that I would necessarily want
- 52:22Speaker 1: to do anything about it. And that's always our threshold
- 52:24Speaker 1: for should I check something? Is the answer going to
- 52:26Speaker 1: make a difference.
- 52:27Speaker 2: I also feel like, what if you tested and it
- 52:30Speaker 2: wasn't like it was like four hundred, and then you
- 52:32Speaker 2: were like, ah, now I have to get tested again
- 52:35Speaker 2: so I can try to Because you're not really like me,
- 52:37Speaker 2: so you probably wouldn't do that. But I feel like
- 52:38Speaker 2: that's the reaction I would have. I'd be like, oh,
- 52:40Speaker 2: what can I do?
- 52:41Speaker 1: Yeah, I mean sometimes just like knowledge is your ignorance
- 52:45Speaker 1: is bliss.
- 52:46Speaker 3: Ignorance is bliss.
- 52:48Speaker 2: All right, Perry, testosterone supplementation smash your pass.
- 52:53Speaker 1: I'm giving this a smash for men with low testosterone
- 52:57Speaker 1: levels who have sexual symptoms. Otherwise it's a past. Emily
- 53:01Speaker 1: Smasher pass.
- 53:02Speaker 2: I concur smash if it is if you have low
- 53:06Speaker 2: levels and it is bothering you otherwise pass.
- 53:11Speaker 1: All right, That is it for testosterone. Your mailbag question
- 53:14Speaker 1: of the week after the Break.
- 53:21Speaker 3: Hi, Emily and Perry.
- 53:22Speaker 7: This is Emily, also from Baltimore. My husband is newly sober, so.
- 53:27Speaker 3: I kind of am now too.
- 53:29Speaker 7: My question is what is the health impact when swapping
- 53:32Speaker 7: a daily alcoholic drink for a daily soda and what's
- 53:36Speaker 7: the impact of soda versus diet soda? In other words,
- 53:40Speaker 7: if the choice is a daily drink of alcohol, diet
- 53:42Speaker 7: soda and regular soda, is there a clear winter health wise?
- 53:46Speaker 7: Love the show, Thanks so much so.
- 53:49Speaker 2: You're asking the question about alcohol, diet soda versus regular soda.
- 53:52Speaker 2: This feels like a fairly straightforward answer, which is, if
- 53:56Speaker 2: we're kind of thinking about some kind of optimizing diet
- 54:00Speaker 2: soda is the winner. It doesn't have the sugar, and
- 54:03Speaker 2: it doesn't have the alcohol. That's different from saying that
- 54:05Speaker 2: you can't have like a healthy lifestyle that incorporates alcohol
- 54:08Speaker 2: or regular soda.
- 54:10Speaker 3: In it in moderation.
- 54:12Speaker 2: But if you're telling me, like I'm a difference between
- 54:14Speaker 2: those three things, I'm going with the diet soda.
- 54:17Speaker 1: Uh yeah, I totally agree. I mean, there is a
- 54:21Speaker 1: lot of concern out there about artificial sweeteners. In fact,
- 54:24Speaker 1: that is on our list of upcoming episodes somewhere our
- 54:28Speaker 1: producer tomorrow can can tell us where that is happening.
- 54:31Speaker 1: But much of this, as you will see in that episode,
- 54:35Speaker 1: is really overblown or hypothetical concerns.
- 54:39Speaker 2: Whereas mice exclusively eats sycrilos as their entire diet forever,
- 54:43Speaker 2: that's not ideal, right, And.
- 54:46Speaker 1: You know, but the concerns we have about alcohol and
- 54:49Speaker 1: about like sugar or corn syrup as you would find
- 54:52Speaker 1: in regular soda is much better documented, much higher level
- 54:57Speaker 1: of evidence. So I think there's a lot of anxiety
- 54:59Speaker 1: about artificial sweeteners. Diet soda water is probably better for
- 55:04Speaker 1: you than drinking that stuff. But if you're purely talking
- 55:08Speaker 1: about health risks, definitely diet soda over alcohol. If you
- 55:12Speaker 1: get the same sort of amount of joy out of it.
- 55:14Speaker 2: Yeah, I mean, I think that point about joy is
- 55:17Speaker 2: important because they think, certainly, you know, I've spent a
- 55:20Speaker 2: lot of time with the alcohol and health literature, and
- 55:23Speaker 2: you know, occasional light drinking is I think the potential
- 55:27Speaker 2: negative impacts are really quite small relative to some of
- 55:31Speaker 2: what you hear. But again, if you're saying, like I'm
- 55:34Speaker 2: totally indifferent, I think this is a clear call, particularly
- 55:38Speaker 2: because this person has specified that like, this is what
- 55:41Speaker 2: works for their relationship and is supportive of their partner,
- 55:44Speaker 2: which makes it an even clearer no brainer.
- 55:46Speaker 1: And also, have you tried diet doctor pepper? Amazing? It's great.
- 55:50Speaker 3: It's too sweet.
- 55:51Speaker 2: I find it too sweet, but diet like a nice
- 55:53Speaker 2: diet coke. Like for me, that's like cannot be spot
- 55:57Speaker 2: fridge cigarette. That's what gen Z calls that cigarette.
- 56:03Speaker 1: Well, that's it for us today. Stick with us next
- 56:06Speaker 1: week when we'll ask what's the deal with colostrum?
- 56:12Speaker 2: Wellness actually is produced in association with iHeartMedia.
- 56:16Speaker 3: Our senior producer is Tamar Avisheid.
- 56:18Speaker 2: Our executive producer at iHeart is Jennifer Bassett. Our theme
- 56:22Speaker 2: music is by Eric Deutsch. And our content is for
- 56:25Speaker 2: educational purposes only.
- 56:26Speaker 1: If you like the show, help other people find us,
- 56:29Speaker 1: leave a rating and review on Apple Podcasts or your
- 56:32Speaker 1: podcatcher of choice, and help us spread the word about
- 56:35Speaker 1: the show. You can follow us on Instagram at Wellness
- 56:38Speaker 1: Actually pod and don't forget We want to hear from you.
- 56:41Speaker 1: Head over to Wellness Actually dot fm and leave us
- 56:44Speaker 1: a question for our mailbag or suggest a topic for
- 56:47Speaker 1: a future show.
- 56:48Speaker 3: We'll let the influencers have the last word.
- 56:50Speaker 1: Yeah.
- 56:51Speaker 8: TESTOSTERM replacement therapy, hormone replacement therapy. Yeah, it makes a big.
- 56:54Speaker 3: Difference, makes a big difference.
- 56:56Speaker 8: Fuck Yeah, there's a stigma attached to that in a
- 56:59Speaker 8: lot of people, like you know, where do you get
- 57:01Speaker 8: your testosterone from? I'll get it from my balls. It's
- 57:06Speaker 8: real simple. If you're fine with not feeling as good good,
- 57:10Speaker 8: go ahead. Stick with that.